FDA Adverse Event Malfunction Summary report: N

TELIGEN

MDR report key: 3771439 · Received April 24, 2014

Report

Report Number
2124215-2014-09142
Event Type
Malfunction
Date Received
April 24, 2014
Date of Event
July 13, 2012
Report Date
May 2, 2016
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWP
PMA / PMN Number
P960040
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
WA
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

UPON RECEIPT AT OUR POST MARKET (B)(4) LABORATORY, A THOROUGH EVALUATION OF THE DEVICE WAS PERFORMED. A VISUAL INSPECTION OF THE DEVICE HEADER AND CASE NOTED NO ANOMALIES. THE DEVICE WAS THEN EXPOSED TO SIMULATED HEART LOAD CONDITIONS, AND THE DEFIBRILLATION, PACING AND SENSING FUNCTIONS WERE TESTED. THE DEVICE OPERATED APPROPRIATELY, ACCORDING TO ITS PERFORMANCE SPECIFICATIONS, WITH NO INTERRUPTIONS IN THERAPY OUTPUT OR PROGRAMMER COMMUNICATION AT THE RETURNED PROGRAMMED SETTINGS. A SERIES OF ELECTRICAL TESTS WAS ALSO PERFORMED, AND AGAIN, NORMAL DEVICE FUNCTION WAS OBSERVED.

Additional Manufacturer Narrative · 1

AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

SUBSEQUENT INFORMATION INDICATES THAT THE DEVICE WAS EXPLANTED FOR AN UNRELATED PRODUCT ISSUE. THE DEVICE WAS RETURNED FOR ANALYSIS.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE PACING IMPEDANCES FOR THE RIGHT ATRIAL (RA) LEAD ROSE FROM 500 OHMS TO 1800 OHMS, ULTIMATELY REACHING GREATER THAN 2,000 OHMS. NO ADVERSE PATIENT EFFECTS REPORTED. A FUTURE APPOINTMENT HAS BEEN MADE FOR THIS PATIENT TO HAVE THEIR SYSTEM CHECKED. THE DEVICE REMAINS IMPLANTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
249059 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWP GUIDANT CRM CLONMEL IRELAND E110

Patients

Seq Age Sex Outcome Treatment
1 72 YR 4456| E110| 4469| S602